CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


CholecalciferolWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)


Name (Synonyms) Correlation
drug173 Angiotensin II Wiki 1.00
drug1229 Interleukin-1 receptor antagonist Wiki 1.00
drug1270 Ivermectin Wiki 0.24
drug262 Azithromycin Wiki 0.17

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Pilot Study for COVID-19 Outpatient Treatment With the Combination of Ivermectin-azithromycin-cholecalciferol

As the world faces COVID-19, the search for effective treatments against the disease and its complications has turned its gaze to drugs that are classically used in other infectious diseases. Some drugs are being examined for the recent evidence on its effects on viral replication and inflammation, one is Azithromycin, used to treat a wide variety of bacterial infections, Ivermectin, an anti-parasitic drug and the other is Cholecalciferol to increase serum concentration of 25-hydroxyvitamin D.

NCT04399746 COVID Drug: Ivermectin Drug: Azithromycin Drug: Cholecalciferol

Primary Outcomes

Description: Test for virus at day 1 and 14 from beginning of trial drug started

Measure: Viral clearance

Time: 14 days

Secondary Outcomes

Description: The duration of symptoms in days

Measure: Symptoms duration

Time: 14 days

Description: oxygen saturation

Measure: SpO2

Time: 14 days

Description: Oxygen Saturation (SpO2)/Fraction of Inspired Oxygen (FiO2) Ratio

Measure: SpO2/FiO2

Time: 14 days


No related HPO nodes (Using clinical trials)